• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 AJUST® ADJUSTABLE SINGLE-INCISION SLING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 AJUST® ADJUSTABLE SINGLE-INCISION SLING Back to Search Results
Catalog Number BRD705SI
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Adhesion(s) (1695); Fatigue (1849); Pain (1994); Scar Tissue (2060); Discomfort (2330); Deformity/ Disfigurement (2360); Urinary Incontinence (4572)
Event Type  Injury  
Manufacturer Narrative
The reported event could not be confirmed.No sample was returned for evaluation.Based on the investigation findings, current manufacturing controls are considered adequate as to detect and segregate any non-conforming unit.Event described could not be confirmed as a manufacturing related issue.The alleged event is most likely associated with possible procedural/surgical complications.The ifu currently addresses potential risks associated with surgically implantable materials.Precautions: the usual precautions associated with urological procedures should be followed: based on physician experience and training, a thorough assessment of each patient should be made to determine their suitability for the implant procedure.Additional consideration should be given to use of the implant in patients with a compromised immune system, any condition that would compromise healing, or any patient with a history of prior abdominal or pelvic surgeries.Consideration should also be given to the ability of the patient to tolerate the surgical procedure.Accepted surgical practice and precautions must be followed for the management of contaminated or infected wound sites, when the ajust¿ sling system is used.Postoperative bleeding may occur in some patients and must be controlled prior to patient release.The implant procedure requires diligent attention to anatomical structures and care to avoid puncture of large vessels, nerves, bladder, bowel, urethra and any viscera, during introducer passage.Due to anatomical distortion that can be caused by pelvic organ prolapse, if the patient requires cystocele repair, it should be performed prior to the implantation of the sub-urethral sling.Proper placement of the sling implant at the mid-urethra requires that it lie flat with minimal or no tension under the urethra.The ajust¿ sling system is intended as a single-use device.Do not resterilize any portion of the ajust¿ sling system.Reuse and/or repackaging may create a risk of patient or user infection, compromise the structural integrity and/or essential material and design characteristics of the device, which may lead to device failure, and/or lead to injury, illness or death of the patient.Patients should be advised that pregnancy following a sling implant procedure may negatively affect the success of the previous implant procedure and incontinence may recur.The safety and effectiveness of the ajust¿ sling system implant procedure has not been established for the treatment of stress urinary incontinence in males or children under the age of 18.Cystoscopy can be considered at the physician¿s discretion.Check the integrity of the packaging before use.Do not use the implant or introducers if the packaging is opened or damaged.As for any implantable material, it is recommended to open the package at the time of implantation.Upon opening the ajust¿ sling system tray, the components should be carefully transferred into the sterile field.The tray should not be inverted to remove components.Post-operatively the patient should be advised to refrain from heavy lifting, exercise (e.G.Cycling, jogging) and/or intercourse until the physician determines it is suitable for the patient to return to normal activities.Adverse events: complications associated with the proper implantation of the ajust¿ sling system may include, but are not limited to: postoperative hematoma, seroma, abscess or fistula formation, or scarring which may occur following the implant procedure.Urinary retention, bladder outlet obstruction and other voiding dysfunctions.These conditions may be associated with over-correction/too much tension placed on the implant.Perforations or lacerations of vessels, nerves, bladder, bowel, urethra, or any viscera, which may occur during the implantation procedure.Irritation at the operative wound site which may elicit a foreign body response that leads to wound dehiscence, inflammation and/or infection.Extrusion through vaginal epithelium or erosion into surrounding viscera and/or mucosa.Inflammation, sensitization, pain, dyspareunia, scarification, contraction, device migration and failure of the procedure resulting in recurrence of incontinence.1994, 1928, 2061 = "l".2348, 1849, 2330, 1695, 2371, 2360 = "nl".
 
Event Description
Per legal court file number: (b)(4).Attorney alleges that the patient was implanted with ajust® adjustable single-incision sling (ref: (b)(4), lot: huua1358) on (b)(6) 2010.It is alleged that patient suffered the development of stress urinary incontinence recurrence and chronic pain.On (b)(6) 2017, the patient underwent another corrective revision surgery with the product.On (b)(6) 2018, the patient underwent another corrective revision surgery with the product.On (b)(6) 2018, the patient underwent another corrective revision surgery.The patient allegedly had suffered injuries, losses, and damages resulting from numerous defects in the product that create an unreasonably high risk of injury with severe permanent adverse health consequences.The implantation and failure of the product has had a devastating impact on the patient, leaving the patient with permanent injuries including scarring, disfigurement, and chronic pain.The patients adverse reaction, complications, and further surgery directly and proximately resulted from the defective and dangerous condition of the product.As a result, the patient sustained injuries, including mesh failure, stress urinary incontinence recurrence, adhesions, chronic pain, chronic fatigue, psychological and emotional injuries.The injuries due to the implantation of the product have caused and continue to cause pain, suffering, loss of enjoyment of life, permanent physical disability, loss of physical, mental and emotional health.Attorney alleges that the device is defective.Per additional information received via medical records on 04jan2022, the patient has experienced recurrence of stress urinary incontinence, chronic pain, permanent injuries including scarring, disfigurement, mesh failure, adhesions, chronic fatigue, psychological and emotional injuries, suffering, permanent physical disability and required additional surgical and nonsurgical interventions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AJUST® ADJUSTABLE SINGLE-INCISION SLING
Type of Device
AJUST® ADJUSTABLE SINGLE-INCISION SLING
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer Contact
yonic anderson
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key13315188
MDR Text Key285421690
Report Number1018233-2022-90001
Device Sequence Number1
Product Code PAH
UDI-Device Identifier00801741168017
UDI-Public(01)00801741168017
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K092607
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 01/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/21/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2012
Device Catalogue NumberBRD705SI
Device Lot NumberHUUA1358
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Device Age5 MO
Event Location Hospital
Date Manufacturer Received01/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/10/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability; Required Intervention;
Patient SexFemale
-
-